Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells.
Ontology highlight
ABSTRACT: Epithelial ovarian cancer (EOC) is one of the most malignant gynecological tumors with a high mortality rate owing to tumor relapse after anticancer therapies. It is widely accepted that a rare tumor cell population, known as cancer stem cells (CSC), is responsible for tumor progression and relapse; intriguingly, these cells are able to survive nutrient starvation (such as in vitro culture in the absence of glucose) and chemotherapy treatment. Recent data also indicated that chemotherapy resistance is associated with autophagy activation. We thus decided to investigate both in vitro and in vivo the autophagic activity and the effects of the perturbation of this pathway in CSC isolated from EOC ascitic effusions. Ovarian CSC, identified according to their CD44/CD117 co-expression, presented
SUBMITTER: Pagotto A
PROVIDER: S-EPMC5550872 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA